|
|
|
Search for: "Chugai"
Roche Receives FDA Clearance for CoaguChek XS Pro system With Bar Code Reader for PT/INR Testing at the Point of Care
HSMN NewsFeed,
26 Jul 2010:
Diagnostics, FDA
[Roche Diagnostics, Roche Group, CoaguChek, warfarin, coumadin]
|
Karen Lackey Named Vice President and Head of Medicinal Chemistry at Roche
HSMN NewsFeed,
26 Jul 2010:
Biopharmaceuticals, Personnel
[Roche Group]
|
FDA Approves New Roche Dual-PCR Target HIV-1 Test
HSMN NewsFeed,
4 Jun 2010:
Diagnostics, FDA, HIV/AIDS
[Roche Molecular Diagnostics, COBAS , AmpliPrep, TaqMan HIV-1]
|
Roche Diagnostics Receives FDA Approval for Qualitative Anti-HCV Immunoassay Test on Three Analyzer Platforms
HSMN NewsFeed,
28 May 2010:
Diagnostics, FDA
[Roche Diagnostics, Elecsys Antibody, hepatitis C]
|
Caris Life Sciences Names Jonathan Knowles, Ph.D., Chief Scientific Officer
HSMN NewsFeed,
19 May 2010:
Diagnostics, Personalized Medicine, Personnel
[Caris Life Sciences]
|
Roche and Biogen Idec Announce Their Decision to Discontinue the ocrelizumab Clinical Development Programme in Patients with Rheumatoid Arthritis
HSMN NewsFeed,
19 May 2010:
Biopharmaceuticals
[Biogen Idec, Roche Group, ocrelizumab, rheumatoid arthritis]
|
Genentech Submits Supplemental Biologics License Application for ACTEMRA(R) (tocilizumab) for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis
HSMN NewsFeed,
16 Mar 2010:
Biopharmaceuticals, FDA
[Genentech, Roche Group, ACTEMRA, tocilizumab, rheumatoid arthritis, LITHE trial]
|
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
HSMN NewsFeed,
17 Feb 2010:
Diagnostics, Oncology
[Roche Molecular Systems, Roche Group, Merck, AmpliChip, p53]
|
OraSure Technologies and Roche Diagnostics Sign Worldwide Commercialization Agreement for Fully Automated Oral Fluid Drugs of Abuse Assays
HSMN NewsFeed,
19 Jan 2010:
Diagnostics
[OraSure Technologies, Roche Group, Roche Diagnostics]
|
FDA Approves ACTEMRA(R) (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
HSMN NewsFeed,
8 Jan 2010:
Biopharmaceuticals, FDA
[Genentech, Roche Group, ACTEMRA, tocilizumab, rheumatoid arthritis]
|
Caris Diagnostics Names New Vice Chairman and Board Member, Dr. Jonathan Knowles
HSMN NewsFeed,
16 Dec 2009:
Diagnostics, Personnel
[Caris Diagnostics]
|
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
HSMN NewsFeed,
16 Dec 2009:
Biopharmaceuticals, Licensing, Venture Capital
[Afferent Pharmaceuticals, Roche Group, P2X31]
|
Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
HSMN NewsFeed,
7 Dec 2009:
Biopharmaceuticals, Oncology
[Genentech, Roche Group, Biogen Idec, Rituxan, rituximab, leukemia]
|
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
HSMN NewsFeed,
2 Dec 2009:
Diagnostics, FDA
[Roche Molecular Systems, cobas s 201, hepatitis]
|
Phase III Study Showed Patients Lived Longer Without Low-Grade Lymphoma Progressing When Rituxan Was Used First-Line for Maintenance
HSMN NewsFeed,
17 Sep 2009:
Biopharmaceuticals, Oncology
[Genentech, Roche Group, Biogen Idec, Rituxan, rituximab]
|
FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
HSMN NewsFeed,
31 Aug 2009:
Biopharmaceuticals, FDA
[Roche Group, Valcyte, valganciclovir, cytomegalovirus]
|
Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
HSMN NewsFeed,
26 May 2009:
Biopharmaceuticals
[Roche Group, LITHE study, ACTEMRA, tocilizumab, rheumatoid arthritis]
|
Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
HSMN NewsFeed,
12 May 2009:
Biopharmaceuticals, Diagnostics, Monitoring, Endocrinology
[Roche Group, ACCU-CHEK, insulin pump, diabetes]
|
CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
HSMN NewsFeed,
5 May 2009:
Biopharmaceuticals, Personnel
[CytRx]
|
Roche Announces Collaboration to Investigate New Treatment Strategy With Tarceva in Lung Cancer
HSMN NewsFeed,
24 Apr 2009:
Biopharmaceuticals, Oncology
[Roche Group, Tarceva, erlotinib, lung cancer, EURTAC trial]
|
Newly Published Study Shows That Re-Treatment With Pegasys(R) (Peginterferon Alfa-2a) Provides Hepatitis C Patients With a Second Chance for a Cure
HSMN NewsFeed,
20 Apr 2009:
Biopharmaceuticals
[Roche Group, Pegasys, Copegus, hepatitis C, peginterferon alfa-2a]
|
Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU
HSMN NewsFeed,
2 Apr 2009:
Diagnostics, Regulatory
[Roche Group, Roche Molecular Systems, LightCycler, MRSA]
|
Roche Completes Tender Offer for Genentech
HSMN NewsFeed,
26 Mar 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Roche Group, Genentech]
|
Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation
HSMN NewsFeed,
12 Mar 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Roche Group, Genentech]
|
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint
HSMN NewsFeed,
11 Mar 2009:
Biopharmaceuticals
[Genentech, Biogen Idec, Rituxan, rituximab, lupus nephritis, lupus]
|
Rockwell Medical Technologies, Inc. Appoints Richard Yocum, M.D. as VP of Drug Development and Medical Affairs
HSMN NewsFeed,
2 Mar 2009:
Biopharmaceuticals, Personnel
[Rockwell Medical Technologies]
|
Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
HSMN NewsFeed,
17 Feb 2009:
Biopharmaceuticals, Licensing
[Romark Laboratories, Chugai Pharmaceutical, Roche Group, nitazoxanide, hepatitis]
|
Roche Commences Tender Offer for Genentech for US$86.50 Per Share in Cash
HSMN NewsFeed,
9 Feb 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Roche Group, Genentech]
|
Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash
HSMN NewsFeed,
30 Jan 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Roche Group, Genentech]
|
FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
HSMN NewsFeed,
31 Dec 2008:
Diagnostics, FDA
[Roche Group, TaqScreen MPX]
|
Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
HSMN NewsFeed,
16 Dec 2008:
Diagnostics, Oncology, Licensing
[Fujirebio Diagnostics, Roche Diagnostics, Roche Group, ovarian cancer]
|
Rituxan in Combination with Chemotherapy Improves Progression-Free Survival in Difficult-to-Treat Form of Blood Cancer
HSMN NewsFeed,
6 Dec 2008:
Biopharmaceuticals, Oncology
[Genentech, Biogen Idec, Rituxan, rituximab, chronic lymphocytic leukemia]
|
European Commission Approval of New Indication for Roche's Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure
HSMN NewsFeed,
4 Dec 2008:
Biopharmaceuticals, Regulatory
[Roche Group, Pegasys, peginterferon alfa-2a, Copegus, ribavirin, hepatitis C]
|
Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
HSMN NewsFeed,
4 Dec 2008:
Biopharmaceuticals
[Roche Group, ACTEMRA, tocilizumab, rheumatoid arthritis]
|
Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
HSMN NewsFeed,
2 Dec 2008:
Biopharmaceuticals, Personnel
[Regado Biosciences]
|
Roche signs definitive agreement to acquire Memory Pharmaceuticals
HSMN NewsFeed,
25 Nov 2008:
Biopharmaceuticals, Mergers & Acquisitions
[Roche Group, Memory Pharmaceuticals]
|
Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals
HSMN NewsFeed,
25 Nov 2008:
Biopharmaceuticals, Mergers & Acquisitions
[Memory Pharmaceuticals, Roche Group]
|
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
HSMN NewsFeed,
5 Sep 2008:
Biopharmaceuticals, Personnel
[Questcor Pharmaceuticals]
|
Monoclonal Antibody Sales to Almost Double in Coming Years
HSMN NewsFeed,
30 Aug 2008:
Biopharmaceuticals
[Monoclonal Antibody]
|
Roche's 454 Sequencing System Used to Determine the Complete Neanderthal Mitochondrial Genome, Establishing When Humans and Neanderthals Diverged
HSMN NewsFeed,
8 Aug 2008:
Diagnostics
[Roche Group, 454 Sequencing]
|
David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
HSMN NewsFeed,
4 Aug 2008:
Biopharmaceuticals, Personnel
[Regado Biosciences]
|
Lung Cancer Epidemic Looming in Asia?
HSMN NewsFeed,
2 Aug 2008:
Biopharmaceuticals, Oncology
[Datamonitor, non-small cell lung cancer]
|
Roche and Response Biomedical Corporation Aim to Reduce 'Vein-to-Brain' Time with New Point-of-Care Cardiac Tests
HSMN NewsFeed,
28 Jul 2008:
Diagnostics, Cardiology
[Roche Group, Response Biomedical, RAMP 200]
|
Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
HSMN NewsFeed,
23 Jul 2008:
Biopharmaceuticals, Mergers & Acquisitions
[ARIUS Research, Roche Group]
|
Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
HSMN NewsFeed,
21 Jul 2008:
Biopharmaceuticals, Mergers & Acquisitions
[Roche Group, Genentech]
|
European Approval for Roche's Pegasys Personalises Treatment for a Subgroup of Hepatitis C Patients: Chance for Cure With Only Four Months of Treatment
HSMN NewsFeed,
26 Jun 2008:
Biopharmaceuticals, Regulatory
[Roche Group, NCORE Study, Pegasys, Copegus, hepatitis C]
|
Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
HSMN NewsFeed,
24 Jun 2008:
Biopharmaceuticals, Personnel
[Stason Pharmaceuticals]
|
ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
HSMN NewsFeed,
13 Jun 2008:
Biopharmaceuticals
[Roche Group, ACTEMRA, tocilizumab, rheumatoid arthritis, AMBITION Study]
|
New Roche Chlamydia Test Approved for Use in European Union
HSMN NewsFeed,
13 Jun 2008:
Diagnostics, Regulatory
[Roche Group, Chlamydia]
|
Genentech and Biogen Idec Announce Top-Line Results from Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus
HSMN NewsFeed,
29 Apr 2008:
Biopharmaceuticals
[Genentech, Rituxan, rituximab, systemic lupus erythematosus]
|
Roche Diagnostics Expands Availability of HCV Immunoassay
HSMN NewsFeed,
8 Apr 2008:
Diagnostics, Regulatory
[Roche Diagnostics, Roche Group, Elecsys Anti-HCV, Hepatitis C]
|
International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
HSMN NewsFeed,
20 Mar 2008:
Biopharmaceuticals
[Roche Group, rheumatoid arthritis, ACTEMRA, tocilizumab, OPTION trial]
|
Roche Statement Regarding Tamiflu U.S. Label Revision
HSMN NewsFeed,
4 Mar 2008:
Biopharmaceuticals, FDA
[Roche Group, Tamiflu, oseltamivir, influenza]
|
Roche Completes Tender Offer for Ventana Shares
HSMN NewsFeed,
19 Feb 2008:
Diagnostics, Mergers & Acquisitions
[Roche Group, Ventana Medical Systems]
|
Genentech and Biogen Idec Announce Positive Results from a Phase III Trial of Rituxan in Patients with Rheumatoid Arthritis Who Inadequately Responded to Methotrexate
HSMN NewsFeed,
25 Jan 2008:
Biopharmaceuticals
[Genentech, Biogen Idec, Rituxan, rituximab, rheumatoid arthritis]
|
Roche to Acquire Ventana for $89.50 per share
HSMN NewsFeed,
22 Jan 2008:
Diagnostics, Mergers & Acquisitions
[Roche Group, Ventana Medical Systems]
|
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
HSMN NewsFeed,
14 Dec 2007:
Biopharmaceuticals, Oncology, Regulatory
[OSI Pharmaceuticals, Genentech, Roche Group, Chugai, Tarceva, erlotinib]
|
Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
HSMN NewsFeed,
21 Nov 2007:
Biopharmaceuticals
[Roche Group, ACTEMRA, tocilizumab, rheumatoid arthritis, interleukin-6]
|
NPS Pharmaceuticals Announces Senior Management Appointments
HSMN NewsFeed,
13 Nov 2007:
Biopharmaceuticals, Personnel
[NPS Pharmaceuticals]
|
Roche Confirms Commencement of Due Diligence with Ventana
HSMN NewsFeed,
13 Nov 2007:
Diagnostics
[Roche Group, Ventana Medical Systems]
|
Roche Extends Tender Offer for Ventana
HSMN NewsFeed,
29 Oct 2007:
Diagnostics, Mergers & Acquisitions
[Roche Group, Ventana Medical Systems]
|
Tarceva(R) (erlotinib) Earns Approval for Lung Cancer Patients in Japan
HSMN NewsFeed,
22 Oct 2007:
Biopharmaceuticals, Oncology, Regulatory
[OSI Pharmaceuticals, Roche Group, Tarceva, erlotinib, NSCLC]
|
Exclusive Agreement Announced Between Quidel Corporation and Roche Pharma AG
HSMN NewsFeed,
26 Sep 2007:
Diagnostics
[Quidel, Roche Group, QuickVue, Tamiflu]
|
Roche Extends Tender Offer for Ventana
HSMN NewsFeed,
19 Sep 2007:
Diagnostics, Mergers & Acquisitions
[Roche Group, Ventana Medical Systems]
|
Aspreva Provides Update On Lupus Nephritis Development Program
HSMN NewsFeed,
10 Sep 2007:
Biopharmaceuticals
[Aspreva Pharmaceuticals, Roche Group, CellCept, lupus nephritis]
|
Roche's Tarceva(R) Delivers Longer Life for Lung Cancer Patients
HSMN NewsFeed,
4 Sep 2007:
Biopharmaceuticals, Oncology
[Roche Group, Tarceva, erlotinib, non-small cell lung cancer]
|
FDA Approves New Roche West Nile Virus Blood Screening Test
HSMN NewsFeed,
28 Aug 2007:
Diagnostics, FDA
[Roche Group, Roche Diagnostics, West Nile Virus, TaqScreen]
|
Aspreva and Roche Update CellCept Agreement
HSMN NewsFeed,
28 Aug 2007:
Biopharmaceuticals
[Aspreva Pharmaceuticals, Roche Group, CellCept]
|
Roche Extends Tender Offer for Ventana
HSMN NewsFeed,
21 Aug 2007:
Diagnostics, Mergers & Acquisitions
[Roche Group, Ventana Medical Systems]
|
Roche Extends Tender Offer for Ventana
HSMN NewsFeed,
26 Jul 2007:
Diagnostics, Mergers & Acquisitions
[Roche Group, Ventana Medical Systems]
|
Roche Announces Expiration of HSR Waiting Period for Ventana Offer
HSMN NewsFeed,
25 Jul 2007:
Diagnostics, Mergers & Acquisitions
[Roche Group, Ventana Medical Systems]
|
Roche Executes Fastest Market Penetration with HIV Viral Load Monitoring Test, COBAS(R) AmpliPrep(R) /COBAS(R) TaqMan(R) HIV-1
HSMN NewsFeed,
16 Jul 2007:
Diagnostics, HIV/AIDS
[Roche Group, Roche Diagnostics, AmpliPrep]
|
Roche Says Offer for Ventana Medical Systems, Inc. is Full and Fair
HSMN NewsFeed,
11 Jul 2007:
Diagnostics, Mergers & Acquisitions
[Roche Group, Ventana Medical Systems]
|
ACTEMRA(TM) (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
HSMN NewsFeed,
10 Jul 2007:
Biopharmaceuticals
[Roche Group, ACTEMRA, RADIATE trial, rheumatoid arthritis]
|
Roche and Alnylam Form Major Alliance on RNAi Therapeutics
HSMN NewsFeed,
9 Jul 2007:
Biopharmaceuticals
[Roche Group, Alnylam Pharmaceuticals, RNAi, RNA interference]
|
Roche Commences Tender Offer for Ventana for $75 Per Share in Cash
HSMN NewsFeed,
27 Jun 2007:
Diagnostics, Mergers & Acquisitions
[Roche Group, Ventana Medical Systems]
|
Aspreva and Roche announce preliminary results for phase III study evaluating CellCept in lupus nephritis
HSMN NewsFeed,
27 Jun 2007:
Biopharmaceuticals
[Aspreva Pharmaceuticals, Roche Group, CellCept, mycophenolate mofetil, lupus]
|
Roche Completes Acquisition of BioVeris
HSMN NewsFeed,
26 Jun 2007:
Diagnostics, Mergers & Acquisitions
[Roche Diagnostics, Roche Group, BioVeris]
|
Roche Makes Offer to Acquire Ventana for $75.00 Per Share in Cash
HSMN NewsFeed,
25 Jun 2007:
Diagnostics, Mergers & Acquisitions
[Roche Group, Ventana Medical Systems]
|
New Study Demonstrates Significant Economic and Clinical Value of NT-proBNP Testing for the Management of Heart Failure
HSMN NewsFeed,
19 Jun 2007:
Diagnostics, Cardiology
[Roche Group, Roche Diagnostics, NT-proBNP]
|
ACTEMRA(TM) (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
HSMN NewsFeed,
15 Jun 2007:
Biopharmaceuticals
[Roche Group, ACTEMRA, rheumatoid arthritis]
|
Latest Data Show MabThera(R) Provides Significant and Sustained Relief From Signs and Symptoms of Rheumatoid Arthritis
HSMN NewsFeed,
13 Jun 2007:
Biopharmaceuticals
[Roche Group, rituximab, rheumatoid arthritis, MabThera]
|
454 Life Sciences Announces the Completion of its Acquisition by Roche
HSMN NewsFeed,
29 May 2007:
Biopharmaceuticals, Mergers & Acquisitions
[454 Life Sciences, Roche Group, CuraGen]
|
Roche Diagnostics Announces Successful Resolution of Urgent Medical Device Correction Of CoaguChek PT Test Strips Used in Anticoagulation Monitoring
HSMN NewsFeed,
23 May 2007:
Diagnostics
[Roche Group, Roche Diagnostics, CoaguChek, PT test, prothrombin time]
|
La Jolla Pharmaceutical Company Names Niv Caviar Chief Business and Financial Officer
HSMN NewsFeed,
10 May 2007:
Biopharmaceuticals, Personnel
[La Jolla Pharmaceutical]
|
AEterna Zentaris Bolsters Management Team with Two Key Positions Named
HSMN NewsFeed,
7 May 2007:
Biopharmaceuticals, Personnel
[AETERNA ZENTARIS]
|
Rituxan(R) Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
HSMN NewsFeed,
1 May 2007:
Biopharmaceuticals, Neurology
[Genentech, Biogen Idec, Rituxan, rituximab, multiple sclerosis]
|
AEterna Zentaris Announces Appointment of New President and CEO
HSMN NewsFeed,
26 Mar 2007:
Biopharmaceuticals, Oncology, Personnel
[AEterna Zentaris]
|
Cobalis Appoints Three Pharmaceutical Industry Executives to Board
HSMN NewsFeed,
20 Feb 2007:
Biopharmaceuticals, Personnel
[Cobalis]
|
New CoaguChek XS System Offers Healthcare Providers Greater Flexibility and Control for Anticoagulation Monitoring at the Point of Care
HSMN NewsFeed,
5 Feb 2007:
Diagnostics
[Roche Diagnostics, CoaguChek, anticoagulation monitor]
|
Roche Continues to Strengthen Research and Development
HSMN NewsFeed,
5 Feb 2007:
Biopharmaceuticals
[Roche Group]
|
pSivida appoints Boston based Managing Director
HSMN NewsFeed,
24 Jan 2007:
Biopharmaceuticals, Drug Delivery, Personnel
[pSivida]
|
Phase III ACTEMRA(TM) (tocilizumab) Study Results Demonstrate Significant Improvement in Signs and Symptoms of Patients with Rheumatoid Arthritis
HSMN NewsFeed,
24 Jan 2007:
Biopharmaceuticals
[Roche , OPTION Trial, ACTEMRA, rheumatoid arthritis]
|
Roche Diagnostics Submits West Nile Virus Blood Screening Test to FDA
HSMN NewsFeed,
17 Jan 2007:
Diagnostics
[Roche Diagnostics, TaqScreen, WNV Test, West Nile Virus]
|
Roche Diagnostics Submits Hepatitis C Viral Load Monitoring Test to FDA
HSMN NewsFeed,
15 Jan 2007:
Diagnostics, FDA
[Roche Diagnostics, Hepatitis C, COBAS AmpliPrep, COBAS TaqMan, HCV Test]
|
Roche and Synosis Therapeutics Announce Partnership to Explore Potential of Five Compounds Targeting the Central Nervous System
HSMN NewsFeed,
4 Jan 2007:
Biopharmaceuticals
[Roche , Synosis Therapeutics]
|
Halozyme and Roche Enter Agreement for the Application of Enhanze, A Novel Technology to Improve Drug Delivery
HSMN NewsFeed,
5 Dec 2006:
Biopharmaceuticals, Drug Delivery
[Roche , Halozyme, Enhanze, recombinant human hyaluronidase, hyaluronidase]
|
New Study Shows ACTEMRA(TM) (tocilizumab) Significantly Improves Remission Rates in Patients with Rheumatoid Arthritis
HSMN NewsFeed,
13 Nov 2006:
Biopharmaceuticals
[Roche , tocilizumab, ACTEMRA, Castleman's Disease, rheumatoid arthritis]
|
Roche Diagnostics and OraSure Technologies Sign Letter of Intent to Develop Fully Automated Oral Fluid Drugs of Abuse Assays
HSMN NewsFeed,
4 Oct 2006:
Diagnostics
[Roche Diagnostics, OraSure Technologies]
|
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
HSMN NewsFeed,
4 Oct 2006:
Biopharmaceuticals, Oncology
[Plexxikon, Roche, PLX4032, BRAF gene]
|
Regeneron Names Peter Powchik, M.D., Senior Vice President of Clinical Development
HSMN NewsFeed,
3 Oct 2006:
Biopharmaceuticals, Personnel
[Regeneron Pharmaceuticals]
|
Alert for BD Logic(R) Meter Users: Roche Diagnostics Offers ACCU-CHEK(R) Blood Glucose Systems
HSMN NewsFeed,
2 Oct 2006:
Diagnostics, Endocrinology
[Roche Diagnostics, ACCU-CHEK, blood glucose system, diabetes]
|
Patients With HER2-Positive Breast Cancer Significantly Benefit From Addition of Xeloda to Herceptin and Taxotere Therapy
HSMN NewsFeed,
2 Oct 2006:
Biopharmaceuticals, Oncology
[Roche , Xeloda, capecitabine, HER2, her-2, Herceptin, Taxotere, breast cancer]
|
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
HSMN NewsFeed,
29 Sep 2006:
Biopharmaceuticals, Oncology, FDA
[Genentech, Biogen Idec, Rituxan, Rituximab, non-Hodgkin's lymphoma]
|
Chugai Pharmaceutical to Establish an Oncology Unit
HSMN NewsFeed,
27 Sep 2006:
Biopharmaceuticals, Oncology
[Chugai Pharmaceutical]
|
Women More Likely to Stay on Once-Monthly Boniva(R) Versus Once-Weekly Osteoporosis Medicines
HSMN NewsFeed,
17 Sep 2006:
Biopharmaceuticals
[GlaxoSmithKline, Roche , Boniva, ibandronate, osteoporosis]
|
Chugai Announces Co-Development and Co-Marketing Agreement with Taisho Pharmaceutical for the Antiresorptive Bisphosphonate R484
HSMN NewsFeed,
12 Sep 2006:
Biopharmaceuticals, Licensing
[Chugai Pharmaceutical, Taisho Pharmaceutical, R484, ibandronic, Bonviva]
|
Xenical(R) Shown to Improve Control of Blood Glucose Levels in People With Type 2 Diabetes Beyond Impact of Weight Loss Alone
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals
[Roche, Xenical, orlistat]
|
Roche Requests Re-Examination of CHMP Opinion on Tarceva in Pancreatic Cancer at the European Medicines Agency
HSMN NewsFeed,
5 Sep 2006:
Biopharmaceuticals, Oncology, Regulatory
[Roche , Tarceva, erlotinib, pancreatic cancer]
|
Genentech and Biogen Idec Announce Positive Results From a Phase II Trial of Rituxan in Relapsing-Remitting Multiple Sclerosis
HSMN NewsFeed,
28 Aug 2006:
Biopharmaceuticals, Neurology
[Genentech, Biogen Idec, Rituxan, Rituximab, multiple sclerosis]
|
Roche Diagnostics and ATCC(R) (American Type Culture Collection) Sign Global Agreement
HSMN NewsFeed,
9 Aug 2006:
Diagnostics
[Roche Diagnostics, ATCC]
|
Cardinal Health Signs Agreement With Roche to Manufacture Tamiflu(R)
HSMN NewsFeed,
10 Jul 2006:
Biopharmaceuticals
[Cardinal Health, Roche , Tamiflu]
|
Analysis of Phase III Study Showed Rituxan(R) Plus Methotrexate Reduced Joint Damage in Rheumatoid Arthritis Patients Who Respond Inadequately to TNF Antagonist Therapies
HSMN NewsFeed,
22 Jun 2006:
Biopharmaceuticals
[Genentech, Rituxan, Rituximab, Rheumatoid Arthritis]
|
Evotec and Roche Form Global Alliance to Jointly Discover Novel Drugs
HSMN NewsFeed,
21 Jun 2006:
Biopharmaceuticals
[Roche , Evotec]
|
Aspreva and Roche Receive Orphan Drug Designation from FDA for Evaluation of CellCept in Rare Autoimmune Disease Pemphigus Vulgaris
HSMN NewsFeed,
6 Jun 2006:
Biopharmaceuticals, FDA
[Aspreva Pharmaceuticals, Roche , orphan drug designation, CellCept]
|
New Xeloda Combination Allows Patients with Stomach Cancer to Live Significantly Longer
HSMN NewsFeed,
5 Jun 2006:
Biopharmaceuticals, Oncology
[Roche, oesophagogastric cancer, REAL 2 study, Xeloda]
|
OSI Pharmaceuticals Announces Submission of New Drug Application for Tarceva(R) in Japan
HSMN NewsFeed,
17 Apr 2006:
Biopharmaceuticals, Oncology, Regulatory
[OSI Pharmaceuticals, Tarceva, erlotinib, non-small cell lung cancer]
|
Genentech and Biogen Idec Submit Supplemental Biologics License Application for First-Line Use of Rituxan(R) in Low-Grade or Follicular CD20-Positive B-Cell Non-Hodgkin's Lymphoma
HSMN NewsFeed,
30 Mar 2006:
Biopharmaceuticals, Oncology, FDA
[Genentech, Biogen Idec, Rituxan, rituximab, non-Hodgkin's lymphoma]
|
ImaRx Therapeutics Bolsters Executive Team
HSMN NewsFeed,
8 Mar 2006:
Biopharmaceuticals, Personnel
[ImaRx Therapeutics]
|
FDA Approves Rituxan(R) - The First Targeted B-Cell Therapy for Treatment of Moderate-to-Severe Rheumatoid Arthritis
HSMN NewsFeed,
28 Feb 2006:
Biopharmaceuticals, FDA
[Genentech, Biogen Idec, Rituxan, Rituximab, methotrexate, rheumatoid arthritis]
|
Roche Files Herceptin for Early-Stage HER2-Positive Breast Cancer With European Authorities
HSMN NewsFeed,
17 Feb 2006:
Biopharmaceuticals, Oncology, Regulatory
[Roche , Genentech, Herceptin, trastuzumab, breast cancer]
|
Genentech Submits Supplemental Biologics License Application for Adjuvant Herceptin(R) in Early-Stage HER2-Positive Breast Cancer
HSMN NewsFeed,
15 Feb 2006:
Biopharmaceuticals, Oncology, FDA
[Genentech, Herceptin, Trastuzumab, breast cancer]
|
Roche Molecular Diagnostics and Applied Biosystems Settle Litigation With Bio-Rad Laboratories
HSMN NewsFeed,
13 Feb 2006:
Diagnostics, Litigation
[Roche Molecular Diagnostics, Applied Biosystems, Applera, MJ Research, Bio-Rad]
|
Corgenix and Rebio Gen, Inc. Sign Extension to Technology Agreement for Hyaluronic Acid
HSMN NewsFeed,
2 Feb 2006:
Diagnostics, Licensing
[Corgenix Medical, Rebio Gen, Fujirebio, Chugai Diagnostics Science]
|
US FDA Joint Advisory Committee Recommends Approval of Weight Loss Drug Orlistat 60 mg Capsules for Over-the-Counter Use
HSMN NewsFeed,
23 Jan 2006:
Biopharmaceuticals, FDA
[Roche, GlaxoSmithKline, Alli , orlistat]
|
FDA Clears NT-proBNP Test for New Risk Stratification Use
HSMN NewsFeed,
3 Jan 2006:
Diagnostics, FDA, Cardiology
[Roche Diagnostics, Elecsys, proBNP test]
|
|
|
 |
Additional items found:
The Network Archive contains
109 additional items
matching: Chugai
<< Members - click the icon at left to display. |
|
| |
|
|
|
|
Public
Feeds 
Full text >>